Literature DB >> 18673218

Storage, expression and function of Fas ligand, the key death factor of immune cells.

Marcus Lettau1, Maren Paulsen, Dieter Kabelitz, Ottmar Janssen.   

Abstract

The TNF family member Fas ligand (FasL) induces apoptosis in Fas-expressing cells and serves as a key death factor in the immune system. It is involved in the termination of immune responses by activation-induced cell death, the selection of thymocytes and T and NK cell-mediated cytotoxicity. FasL also participates in the establishment of immune privilege and contributes to tumor cell survival. Besides its death-inducing capacity, FasL has been implicated in retrograde signal transduction into FasL expressing cells by so-called "reverse signalling". In this context, FasL may also act as an accessory/costimulatory molecule. Dysregulation within the Fas/FasL-system manifests in a severe impairment of the functional integrity and maintenance of immune homeostasis. As its receptor Fas is abundantly expressed in several tissues, the expression of FasL has to be tightly regulated to prevent unwanted damage. At the post-transcriptional level, this is achieved by several independent mechanisms, for example the safe intracellular storage, an activation-dependent mobilization, the association with lipid rafts and the shedding by metalloproteases. Of interest, the intracellular portion of FasL contains a unique proline-rich domain, which plays a major role in the control of FasL transport and expression due to interactions with proteins containing SH3 or WW interaction domains. The detailed analysis of FasL-interacting proteins and their functional characterization provided novel insights into the complex processes regulating FasL expression and signal transduction. This knowledge should allow to improve Fas/FasL-based therapeutical approaches that are currently under development.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18673218     DOI: 10.2174/092986708784872384

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  16 in total

1.  CD8αα+MHC Class II+ Cell with the Capacity To Terminate Autoimmune Inflammation Is a Novel Antigen-Presenting NK-like Cell in Rats.

Authors:  Jean Wu; Colin Carlock; April Ross; Junbo Shim; Yahuan Lou
Journal:  J Immunol       Date:  2016-10-31       Impact factor: 5.422

Review 2.  Pathophysiology of Pediatric Multiple Organ Dysfunction Syndrome.

Authors:  Joseph A Carcillo; Bradley Podd; Rajesh Aneja; Scott L Weiss; Mark W Hall; Timothy T Cornell; Thomas P Shanley; Lesley A Doughty; Trung C Nguyen
Journal:  Pediatr Crit Care Med       Date:  2017-03       Impact factor: 3.624

3.  Local tissue expression of the cell death ligand, fas ligand, plays a central role in the development of extrapulmonary acute lung injury.

Authors:  Rajan K Thakkar; Chun-Shiang Chung; Yaping Chen; Sean F Monaghan; Joanne Lomas-Neira; Daithi S Heffernan; William G Cioffi; Alfred Ayala
Journal:  Shock       Date:  2011-08       Impact factor: 3.454

4.  Myeloid-derived suppressor cells express the death receptor Fas and apoptose in response to T cell-expressed FasL.

Authors:  Pratima Sinha; Olesya Chornoguz; Virginia K Clements; Konstantin A Artemenko; Roman A Zubarev; Suzanne Ostrand-Rosenberg
Journal:  Blood       Date:  2011-03-30       Impact factor: 22.113

5.  Fas ligand expression on T cells is sufficient to prevent prolonged airway inflammation in a murine model of asthma.

Authors:  Jiankun Tong; Bryan S Clay; Caroline M Ferreira; Hozefa S Bandukwala; Tamson V Moore; Kelly M Blaine; Jesse W Williams; Lisa M Hoffman; Kimm J Hamann; Rebecca A Shilling; Joel V Weinstock; Anne I Sperling
Journal:  Am J Respir Cell Mol Biol       Date:  2009-10-23       Impact factor: 6.914

6.  Circulating levels of soluble Fas ligand reflect disease progression in multiple myeloma.

Authors:  Michael G Alexandrakis; Constantina A Pappa; Anna Kolovou; Stavroula Kyriakaki; Rodanthi Vyzoukaki; Maria Devetzoglou; George Tsirakis
Journal:  Med Oncol       Date:  2014-04-13       Impact factor: 3.064

7.  Nck adapter proteins: functional versatility in T cells.

Authors:  Marcus Lettau; Jennifer Pieper; Ottmar Janssen
Journal:  Cell Commun Signal       Date:  2009-02-02       Impact factor: 5.712

8.  Enrichment and analysis of secretory lysosomes from lymphocyte populations.

Authors:  Hendrik Schmidt; Christoph Gelhaus; Ralph Lucius; Melanie Nebendahl; Matthias Leippe; Ottmar Janssen
Journal:  BMC Immunol       Date:  2009-07-29       Impact factor: 3.615

9.  Identification of SH3 domain interaction partners of human FasL (CD178) by phage display screening.

Authors:  Matthias Voss; Marcus Lettau; Ottmar Janssen
Journal:  BMC Immunol       Date:  2009-10-06       Impact factor: 3.615

10.  Interplay between Misplaced Müllerian-Derived Stem Cells and Peritoneal Immune Dysregulation in the Pathogenesis of Endometriosis.

Authors:  Antonio Simone Laganà; Emanuele Sturlese; Giovanni Retto; Vincenza Sofo; Onofrio Triolo
Journal:  Obstet Gynecol Int       Date:  2013-06-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.